Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 121.60
+3.10 (2.62%)
At close: Feb 10, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 54.25 billion as of February 12, 2026. Its market cap has increased by 54.90% in one year.
Market Cap
54.25B
Enterprise Value
61.54B
Revenue
46.34B
Ranking
n/a
PE Ratio
8.54
Stock Price
121.60
Market Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 54.25B, an increase of 2,738.81%. That is a compound annual growth rate of 13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 54.25B | 19.10% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 195.91B |
| Renata | 53.99B |
| Unilever Consumer Care | 42.71B |
| Beacon Pharmaceuticals | 24.72B |
| The ACME Laboratories | 16.12B |
| The IBN SINA Pharmaceutical Industry | 10.82B |
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |